Wings Therapeutics
About:
Wings Therapeutics is a developer of genetic skin disease drug designed to improve the healing and integrity of the skin.
Website: https://www.wings-tx.com/
Description:
Wings Therapeutics is a developer of genetic skin disease drug designed to improve the healing and integrity of the skin. The company's drugs are focused on wound care, pain management and itch management, enabling patients treatment of mutation causing dystrophic epidermolysis bullosa.
Total Funding Amount:
$1.5M
Estimated Revenue Range:
$1M to $10M
Headquarters Location:
Berkeley, California, United States
Founded Date:
2019-01-01
Founders:
Mark De Souza
Number of Employees:
1-10
Last Funding Date:
2019-06-06
IPO Status:
Private
Industries:
© 2025 bioDAO.ai